Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;82:1214-1221

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Volpe, M.
Right arrow Articles by Trimarco, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Volpe, M.
Right arrow Articles by Trimarco, B.

Circulation, Vol 82, 1214-1221, Copyright © 1990 by American Heart Association


ARTICLES

Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans

M Volpe, G Lembo, G Condorelli, N De Luca, F Lamenza, C Indolfi and B Trimarco
I. Clinica Medica, II. Facolta di Medicina, University of Naples, Italy.

The aim of this study was to assess the influence of atrial natriuretic factor (ANF) on arterial baroreflex chronotropic responses and to investigate whether this effect of ANF is affected by angiotensin converting enzyme inhibition (CEI). For this purpose, in 13 normal volunteers, the reflex chronotropic responses to arterial baroreceptor stimulation (phenylephrine, 25-100 micrograms i.v.) or deactivation (nitroglycerin, 25-100 micrograms i.v.) were evaluated in control conditions and during the steady-state phase of a sustained infusion of ANF (50 ng/kg/min) or placebo, before and during prolonged treatment with the converting enzyme inhibitor enalapril (20 mg p.o. for 5 days). ANF infusion, which raised plasma ANF levels from 48 +/- 19 to 1,765 +/- 203 pg/ml, was associated with a slight decrease in systemic blood pressure and no change in heart rate. In addition, it caused a significant increase of the regression slope obtained with phenylephrine (from 11.3 +/- 2 to 18.5 +/- 2 msec/mm Hg) and a significant reduction of slope of the nitroglycerin-produced regression line (from 9.3 +/- 1 to 5.6 +/- 0.6 msec/mm Hg). After sustained CEI, which raised plasma renin activity from 1.4 +/- 0.4 to 19.9 +/- 5 ng/ml/hr, ANF infusion induced an increase in plasma ANF levels and a reduction in blood pressure comparable to those observed in control conditions. During CEI, however, ANF infusion had no significant effect on the chronotropic baroreflex responses produced by phenylephrine or nitroglycerin. Chronotropic and pressor responses to cold exposure were unchanged after CEI and during ANF.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Eur Heart JHome page
C Briguori, S Betocchi, F Manganelli, B Gigante, M.A Losi, Q Ciampi, R Gottilla, A Violante, C.G Tocchetti, M Volpe, et al.
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy
Eur. Heart J., August 1, 2001; 22(15): 1328 - 1336.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats
The role of C-type natriuretic peptide in cardiovascular medicine
Eur. Heart J., June 2, 2001; 22(12): 997 - 1007.
[PDF]


Home page
HypertensionHome page
C. J. Thomas, G. A. Head, and R. L. Woods
ANP and Bradycardic Reflexes in Hypertensive Rats : Influence of Cardiac Hypertrophy
Hypertension, September 1, 1998; 32(3): 548 - 555.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Volpe, P. Magri, M. A. E. Rao, S. Cangianiello, L. DeNicola, A. F. Mele, B. Memoli, I. Enea, S. Rubattu, B. Gigante, et al.
Intrarenal Determinants of Sodium Retention in Mild Heart Failure : Effects of Angiotensin-Converting Enzyme Inhibition
Hypertension, August 1, 1997; 30(2): 168 - 176.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. W. Jahnke, R. Leyh, A. Bernhard, and H. H. Sievers
ATRIAL NATIURETIC PEPTIDE RELEASE AT REST AND WITH EXERCISE AFTER CARDIAC TRANSPLANTATION WITH BICAVAL ANASTOMOSES
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1600 - 1605.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Volpe, M. A.E. Rao, A. Cuocolo, R. Russo, A. Nappi, A. F. Mele, I. Enea, B. Trimarco, and M. Condorelli
Radionuclide Monitoring of Cardiac Adaptations to Volume Loading in Patients With Dilated Cardiomyopathy and Mild Heart Failure : Effects of Angiotensin-Converting Enzyme Inhibition
Circulation, November 1, 1995; 92(9): 2511 - 2518.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. C. Butler, B. L. Senn, and J. S. Floras
Influence of Atrial Natriuretic Factor on Spontaneous Baroreflex Sensitivity for Heart Rate in Humans
Hypertension, June 1, 1995; 25(6): 1167 - 1171.
[Abstract] [Full Text]